Top Cancer Stocks in China
Browse the largest China companies in the world ranked by their Market Capitalization. Global Cancer Companies in China market cap is $36.35B.
20 Jan 2025, 09:33 UTC
Companies: 37
🇨🇳1 |  | $7.72 | 0.00% | 6.50B | 28.21% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳2 |  | $8.46 | 1.68% | 3.81B | 47.47% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳3 |  | $7.45 | -0.82% | 3.12B | 5.21% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳4 |  | $22.18 | -0.12% | 2.81B | 68.59% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳5 |  | $5.85 | 0.87% | 2.39B | -10.76% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳6 |  | $8.51 | 0.10% | 2.25B | 17.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳7 |  | $3.21 | -2.21% | 1.28B | 6.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳8 |  | $1.87 | 0.28% | 1.18B | -59.16% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳9 |  | $2.75 | 0.15% | 1.14B | -52.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳10 |  | $4.09 | -0.31% | 1.13B | -35.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳11 | | $1.82 | -1.69% | 1.12B | -54.66% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳12 |  | $2.65 | -1.07% | 1.09B | -11.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳13 |  | $1.57 | -6.92% | 901.59M | -24.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳14 |  | $5.65 | 1.43% | 894.21M | -35.47% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳15 |  | $1.26 | -0.65% | 808.87M | -13.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳16 |  | $6.55 | 0.77% | 672.52M | 611.96% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳17 |  | $0.61 | -2.20% | 626.69M | -34.27% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳18 |  | $0.34 | 0.00% | 547.62M | -34.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳19 |  | $0.73 | -6.01% | 525.90M | -4.66% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳20 |  | $1.20 | -2.10% | 467.56M | -45.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳21 |  | $1.66 | -1.87% | 438.90M | 5.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳22 |  | $4.17 | -1.36% | 413.11M | -41.24% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳23 |  | $0.30 | 0.00% | 389.92M | 3.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳24 |  | $0.56 | -0.92% | 360.31M | 19.01% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳25 |  | $3.20 | 0.00% | 297.77M | 494.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳26 |  | $0.21 | 0.00% | 159.18M | -18.37% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳27 |  | $0.31 | 0.00% | 158.99M | -52.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳28 |  | $0.66 | 0.39% | 150.35M | -82.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳29 |  | $0.04 | 0.00% | 146.01M | -38.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳30 |  | $0.42 | 3.83% | 108.04M | -57.24% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳31 |  | $0.80 | 46.34% | 88.83M | -30.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳32 |  | $1.94 | 3.19% | 85.04M | -1.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳33 |  | $0.90 | -7.50% | 74.36M | -51.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳34 |  | $0.17 | 0.78% | 68.88M | -42.73% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳35 |  | $0.08 | 8.20% | 57.34M | -67.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳36 |  | $0.12 | -1.02% | 55.88M | -41.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳37 |  | $2.82 | 5.22% | 37.57M | -60.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
